Dr. Duffield is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-5900
Education & Training
- Johns Hopkins UniversityFellowship, Hematopathology, 2009 - 2010
- Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2005 - 2009
- Yale School of MedicineClass of 2005
Certifications & Licensure
- NY State Medical License 2020 - 2025
- NJ State Medical License 2021 - 2023
- MD State Medical License 2010 - 2020
- PA State Medical License 2008 - 2010
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 202 citationsLong interspersed element-1 protein expression is a hallmark of many human cancersNemanja Rodić, Reema Sharma, Rajni Sharma, John G. Zampella, Lixin Dai
The American Journal of Pathology. 2014-05-01 - 72 citationsA Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure.Amer M. Zeidan, Hanna A. Knaus, Tara M. Robinson, Andrea M. H. Towlerton, Edus H. Warren
Clinical Cancer Research. 2018-08-01 - 2 citationsLimited sinonasal Rosai-Dorfman disease presenting as chronic sinusitis.Lisa M Rooper, Marissa J White, Amy S Duffield, Jeffrey Gagan, Nyall R London Jr
Histopathology. 2022-07-01
Abstracts/Posters
- DOCK2 Expression Affects Leukemogenesis and Disease Progression in a Murine Model of FLT3/ITD Acute Myeloid LeukemiaAmy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The High Mobility Group A1 Chromatin Regulator Is Required for Pathologic Megakaryocyte Development and Progression to Myelofibrosis in JAK2V617F Murine ModelsAmy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Gilteritinib and Venetoclax Synergize to Eliminate FLT3/ITD+ Leukemia Cells through BIMAmy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Journal of HematopathologyFebruary 20th, 2019
- Researchers Link Organ Transplant Drug to Rise in Rare LymphomaFebruary 10th, 2016
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/amy-duffield
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: